These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 11368130)

  • 21. Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysis.
    Shah NR; Jones JB; Aperi J; Shemtov R; Karne A; Borenstein J
    Obstet Gynecol; 2008 May; 111(5):1175-82. PubMed ID: 18448752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SSRIs for premenstrual dysphoric disorder.
    Drug Ther Bull; 2002 Sep; 40(9):70-2. PubMed ID: 12298224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuous or intermittent dosing with sertraline for patients with severe premenstrual syndrome or premenstrual dysphoric disorder.
    Freeman EW; Rickels K; Sondheimer SJ; Polansky M; Xiao S
    Am J Psychiatry; 2004 Feb; 161(2):343-51. PubMed ID: 14754784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Premenstrual dysphoric disorder in adolescents: case reports of treatment with fluoxetine and review of the literature.
    Silber TJ; Valadez-Meltzer A
    J Adolesc Health; 2005 Dec; 37(6):518-25. PubMed ID: 16310133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Luteal phase administration of paroxetine for the treatment of premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled trial in Canadian women.
    Steiner M; Ravindran AV; LeMelledo JM; Carter D; Huang JO; Anonychuk AM; Simpson SD
    J Clin Psychiatry; 2008 Jun; 69(6):991-8. PubMed ID: 18517289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluoxetine (Sarafem) for premenstrual dysphoric disorder.
    Med Lett Drugs Ther; 2001 Jan; 43(1096):5-6. PubMed ID: 11177220
    [No Abstract]   [Full Text] [Related]  

  • 27. Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder.
    Halbreich U; Bergeron R; Yonkers KA; Freeman E; Stout AL; Cohen L
    Obstet Gynecol; 2002 Dec; 100(6):1219-29. PubMed ID: 12468166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intermittent fluoxetine dosing in the treatment of women with premenstrual dysphoria.
    Steiner M; Korzekwa M; Lamont J; Wilkins A
    Psychopharmacol Bull; 1997; 33(4):771-4. PubMed ID: 9493491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Venlafaxine in the treatment of premenstrual dysphoric disorder.
    Freeman EW; Rickels K; Yonkers KA; Kunz NR; McPherson M; Upton GV
    Obstet Gynecol; 2001 Nov; 98(5 Pt 1):737-44. PubMed ID: 11704162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: a randomized controlled trial.
    Freeman EW; Rickels K; Sondheimer SJ; Polansky M
    Arch Gen Psychiatry; 1999 Oct; 56(10):932-9. PubMed ID: 10530636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paroxetine controlled release for premenstrual dysphoric disorder: a double-blind, placebo-controlled trial.
    Cohen LS; Soares CN; Yonkers KA; Bellew KM; Bridges IM; Steiner M
    Psychosom Med; 2004; 66(5):707-13. PubMed ID: 15385695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of fluoxetine in the treatment of premenstrual dysphoric disorder.
    Romano S; Judge R; Dillon J; Shuler C; Sundell K
    Clin Ther; 1999 Apr; 21(4):615-33; discussion 613. PubMed ID: 10363729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of premenstrual syndrome with fluoxetine: a double-blind, placebo-controlled, crossover study.
    Wood SH; Mortola JF; Chan YF; Moossazadeh F; Yen SS
    Obstet Gynecol; 1992 Sep; 80(3 Pt 1):339-44. PubMed ID: 1495689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Psychiatric and psychological aspects of premenstrual syndrome].
    Limosin F; Ades J
    Encephale; 2001; 27(6):501-8. PubMed ID: 11865558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Luteal phase dosing with paroxetine controlled release (CR) in the treatment of premenstrual dysphoric disorder.
    Steiner M; Hirschberg AL; Bergeron R; Holland F; Gee MD; Van Erp E
    Am J Obstet Gynecol; 2005 Aug; 193(2):352-60. PubMed ID: 16098854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low doses of fluoxetine for the treatment of emotional premenstrual syndrome: a randomized double-blind, placebo-controlled, pilot study.
    Maranho MCMF; Guapo VG; de Rezende MG; Vieira CS; Brandão ML; Graeff FG; Lovick T; Del-Ben CM
    Psychoneuroendocrinology; 2023 Nov; 157():106360. PubMed ID: 37572412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A double-blind trial of four medications to treat severe premenstrual syndrome.
    Diegoli MS; da Fonseca AM; Diegoli CA; Pinotti JA
    Int J Gynaecol Obstet; 1998 Jul; 62(1):63-7. PubMed ID: 9722128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective serotonin reuptake inhibitors for premenstrual dysphoric disorder: the emerging gold standard?
    Pearlstein T
    Drugs; 2002; 62(13):1869-85. PubMed ID: 12215058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of premenstrual dysphoric disorder with selective serotonin reuptake inhibitors.
    Luisi AF; Pawasauskas JE
    Pharmacotherapy; 2003 Sep; 23(9):1131-40. PubMed ID: 14524645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluoxetine in the treatment of premenstrual syndrome.
    Ozeren S; Corakçi A; Yücesoy I; Mercan R; Erhan G
    Eur J Obstet Gynecol Reprod Biol; 1997 Jun; 73(2):167-70. PubMed ID: 9228499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.